The experimental drug Trump received hours after being diagnosed with COVID-19 was provided under a “compassionate use” program usually reserved for patients who exhaust other treatment options, the manufacturer said — what does this even mean ? https://t.co/ikBybKXFVT

— Suchitra Vijayan 🇵🇸 (@suchitrav) October 2, 2020